% alzhub.org library filter
% Source: https://alzhub.org/research?author=Sabbagh+M&access=free
% 7 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{salloway2014-24450891,
  author  = {Salloway, S. and Sperling, R. and Fox, N. C. and Blennow, K. and Klunk, W. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others},
  title   = {{Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease}},
  journal = {The New England journal of medicine},
  year    = {2014},
  doi     = {10.1056/nejmoa1304839},
  pmid    = {24450891},
  url     = {https://doi.org/10.1056/nejmoa1304839}
}

@article{salloway2009-19923550,
  author  = {Salloway, S. and Sperling, R. and Gilman, S. and Fox, N. C. and Blennow, K. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others},
  title   = {{A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2009},
  doi     = {10.1212/wnl.0b013e3181c67808},
  pmid    = {19923550},
  url     = {https://doi.org/10.1212/wnl.0b013e3181c67808}
}

@article{burstein2014-24423155,
  author  = {Burstein, A. H. and Grimes, I. and Galasko, D. R. and Aisen, P. S. and Sabbagh, M. and Mjalli, A. M.},
  title   = {{Effect of TTP488 in patients with mild to moderate Alzheimer's disease}},
  journal = {BMC neurology},
  year    = {2014},
  doi     = {10.1186/1471-2377-14-12},
  pmid    = {24423155},
  url     = {https://doi.org/10.1186/1471-2377-14-12}
}

@article{bahureksa2017-27172932,
  author  = {Bahureksa, L. and Najafi, B. and Saleh, A. and Sabbagh, M. and Coon, D. and Mohler, M. J. and Schwenk, M.},
  title   = {{The Impact of Mild Cognitive Impairment on Gait and Balance: A Systematic Review and Meta-Analysis of Studies Using Instrumented Assessment}},
  journal = {Gerontology},
  year    = {2017},
  doi     = {10.1159/000445831},
  pmid    = {27172932},
  url     = {https://doi.org/10.1159/000445831}
}

@article{sperling2012-22305802,
  author  = {Sperling, R. and Salloway, S. and Brooks, D. J. and Tampieri, D. and Barakos, J. and Fox, N. C. and Raskind, M. and Sabbagh, M. and others},
  title   = {{Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis}},
  journal = {The Lancet. Neurology},
  year    = {2012},
  doi     = {10.1016/s1474-4422(12)70015-7},
  pmid    = {22305802},
  url     = {https://doi.org/10.1016/s1474-4422(12)70015-7}
}

@article{baumel2021-33368017,
  author  = {Baumel, B. S. and Doraiswamy, P. M. and Sabbagh, M. and Wurtman, R.},
  title   = {{Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review}},
  journal = {Neurology and therapy},
  year    = {2021},
  doi     = {10.1007/s40120-020-00227-y},
  pmid    = {33368017},
  url     = {https://doi.org/10.1007/s40120-020-00227-y}
}

@article{mehta2017-28460541,
  author  = {Mehta, D. and Jackson, R. and Paul, G. and Shi, J. and Sabbagh, M.},
  title   = {{Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015}},
  journal = {Expert opinion on investigational drugs},
  year    = {2017},
  doi     = {10.1080/13543784.2017.1323868},
  pmid    = {28460541},
  url     = {https://doi.org/10.1080/13543784.2017.1323868}
}